Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.720
+0.090 (5.52%)
May 8, 2025, 4:00 PM - Market closed
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $37.83 million as of May 8, 2025. Its market cap has decreased by -53.07% in one year.
Market Cap
37.83M
Enterprise Value
24.96M
1-Year Change
-53.07%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $37.83M, a decrease of -76.19%. That is a compound annual growth rate of -16.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 35.80M | -28.11% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.25B |
| Johnson & Johnson | 376.09B |
| UnitedHealth Group | 354.30B |
| AbbVie | 329.05B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 235.16B |
| AstraZeneca | 217.30B |
| Novartis AG | 215.89B |